Literature DB >> 25585587

[Innovative techniques in atrial fibrillation therapy].

A Metzner1, E Wissner, T Fink, F Ouyang, K-H Kuck.   

Abstract

Pulmonary vein isolation (PVI) is the established cornerstone in most catheter-based ablation treatment strategies for atrial fibrillation (AF); however, it is still a challenge to create contiguous, transmural and permanent ablation lesions using radiofrequency current in combination with three-dimensional mapping systems. To overcome these limitations, innovative spiral mapping and ablation catheters as well as balloon-based ablation catheters incorporating alternative energy sources, such as cryoenergy and laser were developed and evaluated and have proved their potential for safe and clinically effective PVI. In addition, novel ablation strategies, such as identification and ablation of AF-inducing foci and/or AF-perpetuating rotors using either endocardial or epicardial mapping systems were introduced and are currently under clinical evaluation. The identification and modulation of atrial ganglionic plexi (GP) and, therefore, of the autonomous nervous system is another additive ablation approach which requires further clinical evaluation.

Entities:  

Mesh:

Year:  2015        PMID: 25585587     DOI: 10.1007/s00059-014-4194-y

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  38 in total

1.  The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon.

Authors:  Andreas Metzner; Peter Rausch; Christine Lemes; Bruno Reissmann; Alexander Bardyszewski; Roland Tilz; Andreas Rillig; Shibu Mathew; Sebastian Deiss; Masashi Kamioka; Tobias Toennis; Tina Lin; Feifan Ouyang; Karl-Heinz Kuck; Erik Wissner
Journal:  J Cardiovasc Electrophysiol       Date:  2014-01-30

2.  Two versus one repeat freeze-thaw cycle(s) after cryoballoon pulmonary vein isolation: the alster extra pilot study.

Authors:  Kyoung Ryul Julian Chun; Alexander Fürnkranz; Ilka Köster; Andreas Metzner; Tobias Tönnis; Peter Wohlmuth; Erik Wissner; Boris Schmidt; Feifan Ouyang; Karl Heinz Kuck
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-04

3.  Acute safety and efficacy of a novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation.

Authors:  Thomas Deneke; Anja Schade; Patrick Müller; Rainer Schmitt; Georgios Christopoulos; Joachim Krug; Geza Szöllösi; Andreas Mügge; Sebastian Kerber; Karin Nentwich
Journal:  J Cardiovasc Electrophysiol       Date:  2013-12-04

4.  Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report.

Authors:  Michel Haissaguerre; Meleze Hocini; Ashok J Shah; Nicolas Derval; Frederic Sacher; Pierre Jais; Remi Dubois
Journal:  J Cardiovasc Electrophysiol       Date:  2013-02-01

5.  Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon.

Authors:  Ruben Casado-Arroyo; Gian-Battista Chierchia; Giulio Conte; Moisés Levinstein; Juan Sieira; Moises Rodriguez-Mañero; Giacomo di Giovanni; Yannis Baltogiannis; Kristel Wauters; Carlo de Asmundis; Andrea Sarkozy; Pedro Brugada
Journal:  Heart Rhythm       Date:  2013-07-24       Impact factor: 6.343

6.  Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon.

Authors:  Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Melanie Gunawardene; Britta Schulte-Hahn; Verena Urban; Frank Bode; Bernd Nowak; Julian K R Chun
Journal:  J Cardiovasc Electrophysiol       Date:  2013-02-11

7.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

8.  Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation).

Authors:  Sanjiv M Narayan; David E Krummen; Paul Clopton; Kalyanam Shivkumar; John M Miller
Journal:  J Am Coll Cardiol       Date:  2013-04-03       Impact factor: 24.094

9.  Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale.

Authors:  Atul Verma; Prashanthan Sanders; Laurent Macle; Isabel Deisenhofer; Carlos A Morillo; Jian Chen; Chen-yang Jiang; Sabine Ernst; Roberto Mantovan
Journal:  Am Heart J       Date:  2012-07       Impact factor: 4.749

10.  Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial.

Authors:  Demosthenes G Katritsis; Evgeny Pokushalov; Alexander Romanov; Eleftherios Giazitzoglou; George C M Siontis; Sunny S Po; A John Camm; John P A Ioannidis
Journal:  J Am Coll Cardiol       Date:  2013-08-21       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.